Why the study?
Do atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) elicit differential responses in pulmonary arteries versus veins of newborn lambs?
Do atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) elicit differential responses in pulmonary arteries versus veins of newborn lambs?
In the newborn pulmonary circulation, arteries are the major site of action for ANP (mediated by NPR-A), while veins are the major site for CNP (mediated by NPR-B).
Supports vessel-specific natriuretic peptide effects in neonatal lambs; hypothesis-generating for targeted therapies but leaves open human translation.
Atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) are important dilators of the pulmonary circulation during the perinatal period. We compared the responses of pulmonary arteries (PA) and veins (PV) of newborn lambs to these peptides. ANP caused a greater relaxation of PA than of PV, and CNP caused a greater relaxation of PV than of PA. RIA showed that ANP induced a greater increase in cGMP content of PA than CNP. In PV, ANP and CNP caused a similar moderate increase in cGMP content. Receptor binding study showed more specific binding sites for ANP than for CNP in PA and more for CNP than for ANP in PV. Relative quantitative RT-PCR for natriuretic peptide receptor A (NPR-A) and B (NPR-B) mRNAs show that, in PA, NPR-A mRNA is more prevalent than NPR-B mRNA, whereas, in PV, NPR-B mRNA is more prevalent than NPR-A mRNA. In conclusion, in the pulmonary circulation, arteries are the major site of action for ANP, and veins are the major site for CNP. Furthermore, the differences in receptor abundance and the involvement of a cGMP-independent mechanism may contribute to the heterogeneous effects of the natriuretic peptides in PA and PV of newborn lambs.
No takes yet. Share an insight, caveat, or question.
Tolsa et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: